Polysomnography for Obstructive Sleep Apnea Should Include Arousal-Based Scoring: An American Academy of Sleep Medicine Position Statement

Similar documents
Κλινικό Φροντιστήριο Αναγνώριση και καταγραφή αναπνευστικών επεισοδίων Λυκούργος Κολιλέκας Επιμελητής A ΕΣΥ 7η Πνευμονολογική Κλινική ΝΝΘΑ Η ΣΩΤΗΡΙΑ

Coding for Sleep Disorders Jennifer Rose V. Molano, MD

Polysomnography (PSG) (Sleep Studies), Sleep Center

PORTABLE OR HOME SLEEP STUDIES FOR ADULT PATIENTS:

Sleep Studies: Attended Polysomnography and Portable Polysomnography Tests, Multiple Sleep Latency Testing and Maintenance of Wakefulness Testing

Sleep and the Heart Reversing the Effects of Sleep Apnea to Better Manage Heart Disease

The AASM Manual for the Scoring of Sleep and Associated Events

Works Cited 1. A Quantitative Assessment of Sleep Laboratory Activity in the United States. Tachibana N, Ayas NT, White DP. 2005, J Clin Sleep Med,

(To be filled by the treating physician)

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

The most accurate predictors of arterial hypertension in patients with Obstructive Sleep Apnea Syndrome

SleepView. SleepView. Monitor + SleepViewSM. Portal Clinical Validation Summary. CliniCal validation

FEP Medical Policy Manual

Healthy Sleep. Frederick Tolle, M.D., dabsm Community Health Network

Outcome Measures in OSA Defining Our Treatment Goal. Defining common outcome metrics in OSA Al-Shawwa Sleep Med Rev 2008

CHANGING SHAPE OF SLEEP STUDIES

Premier Health Plan considers Oral Appliances for Obstructive Sleep Apnea (OSA) medically necessary for the following indications:

PEDIATRIC SLEEP GUIDELINES Version 1.0; Effective

Obstructive Sleep Apnea

Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea

Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea

Sleep 101. Kathleen Feeney RPSGT, RST, CSE Business Development Specialist

3/13/2014. Home Sweet Home? New Trends in Testing for Obstructive Sleep Apnea. Disclosures. No relevant financial disclosures

RESEARCH PACKET DENTAL SLEEP MEDICINE

Mario Kinsella MD FAASM 10/5/2016

The AASM Manual for the Scoring of Sleep and Associated Events

QUESTIONS FOR DELIBERATION

Writing Committee. Amir Qaseem, MD, PhD, MHA; Laurel Borowski, MPH; Robert A. Gluckman, MD; Nasseer A. Masoodi, MD; and David W.

Policy Specific Section: October 1, 2010 January 21, 2013

Basics of Polysomnography. Chitra Lal, MD, FCCP, FAASM Assistant professor of Medicine, Pulmonary, Critical Care and Sleep, MUSC, Charleston, SC

Index SLEEP MEDICINE CLINICS. Note: Page numbers of article titles are in boldface type.

Clinical Practice Guideline on the Use of Actigraphy for the Evaluation of Sleep Disorders and Circadian Rhythm Sleep-Wake Disorders

11/13/2017. Jeremy Tabak MD, FAASM Medical Director Baptist Hospital Sleep Lab Medical Director Baptist Sleep Lab at Galloway

General Outline. General Outline. Pathogenesis of Metabolic Dysfunction in Sleep Apnea: The Role of Sleep Fragmentation and Intermittent Hypoxemia

Split Night Protocols for Adult Patients - Updated July 2012

A Deadly Combination: Central Sleep Apnea & Heart Failure

Eszopiclone and Zolpidem Do Not Affect the Prevalence of the Low Arousal Threshold Phenotype

Introducing the WatchPAT 200 # 1 Home Sleep Study Device

Underdiagnosis of Sleep Apnea Syndrome in U.S. Communities

Update on Sleep Apnea Diagnosis and Treatment

Clinical Trials in OSA

SLEEP DISORDERED BREATHING The Clinical Conditions

obstructive sleep apnea : OSA OSA obstructive sleep apnea : OSA Verga nasal continuous positive airway pressure ; CPAP OSA OSA OSA CPAP CPAP 3D OSA

Medicare CPAP/BIPAP Coverage Criteria

Medicare C/D Medical Coverage Policy. Respiratory Assist Devices for Obstructive Sleep Apnea and Breathing Related Sleep Disorders

Prefabricated Oral Appliances for Obstructive Sleep Apnea

Management of OSA in the Acute Care Environment. Robert S. Campbell, RRT FAARC HRC, Philips Healthcare May, 2018

New Government O2 Criteria and Expert Panel. Jennifer Despain, RPSGT, RST, AS

(HST) (95806, G0398, G0399)

11/20/2015. Eighth Bi-Annual Pediatric Sleep Medicine Conference. November 12-15, 2015 Omni Amelia Island Plantation Resort Amelia Island, Florida

Sleep Apnea in Women: How Is It Different?

Sleep Apnea: Diagnosis & Treatment

Web-Based Home Sleep Testing

UIHC Home Sleep Apnea Testing (HSAT)

What IS Sleep Apn(o)ea, Anyway? (Why definitions and Metrics Matter) Barbara Phillips, MD,

Positive Airway Pressure and Oral Devices for the Treatment of Obstructive Sleep Apnea

Obstructive sleep apnoea How to identify?

Obstructive Sleep Apnea and COPD overlap syndrome. Financial Disclosures. Outline 11/1/2016

Managed Care and Sleep Medicine

Quality ID #278: Sleep Apnea: Positive Airway Pressure Therapy Prescribed National Quality Strategy Domain: Effective Clinical Care

Sleep Diordered Breathing (Part 1)

Obstructive Sleep Apnea In The Perioperative Setting. Christopher Karcher, MD Diplomate, ABPN Medical Director The Neuroscience Sleep Center

Sleep Disorders in Spinal Cord Injury: Challenges and Opportunities

FEP Medical Policy Manual

Index SLEEP MEDICINE CLINICS. Note: Page numbers of article titles are in boldface type. Cerebrospinal fluid analysis, for Kleine-Levin syndrome,

Respiratory Inductance Plethysmography Improved Diagnostic Sensitivity and Specificity of Obstructive Sleep Apnea

PVDOMICS. Sleep Core. Cleveland Clinic Cleveland, Ohio

sleepview by midmark Home Sleep Test

Sleep Medicine. Maintenance of Certification Examination Blueprint. Purpose of the exam

DECLARATION OF CONFLICT OF INTEREST

Pediatric Sleep-Disordered Breathing

OSA OBSTRUCTIVE SLEEP APNEA

Original Effective Date: Subject: Expiratory Positive Airway Pressure (EPAP) for Obstructive Sleep Apnea 10/30/13

2016 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older)

Effect of Manual Editing of Total Recording Time: Implications for Home Sleep Apnea Testing

Fabrice Czarnecki, M.D., M.A., M.P.H., FACOEM I have no disclosures to make.

Dr. Karan Madan Senior Resident

Sleep Apnea: Vascular and Metabolic Complications

High Flow Nasal Cannula in Children During Sleep. Brian McGinley M.D. Associate Professor of Pediatrics University of Utah

Auto Servo Ventilation Indications, Basics of Algorithm, and Titration

Polycystic Ovarian Syndrome and Obstructive Sleep Apnea: Poor Bedpartners. M. Begay, MD UNM Sleep Medicine Fellow 01/31/2017

The identification of obstructive apneas and hypopneas in

Polysomnography - Sleep Studies

PEDIATRIC OBSTRUCTIVE SLEEP APNEA (OSA)

Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015

OBSTRUCTIVE SLEEP APNEA and WORK Treatment Update

A new beginning in therapy for women

1/27/2017 RECOGNITION AND MANAGEMENT OF OBSTRUCTIVE SLEEP APNEA: STRATEGIES TO PREVENT POST-OPERATIVE RESPIRATORY FAILURE DEFINITION PATHOPHYSIOLOGY

Is CPAP helpful in severe Asthma?

AASM guidelines, when available. Does this mean if our medical director chooses for us to use an alternative rule that our accreditation is at risk?

FAQ CODING & REIMBURSEMENT. WatchPAT TM Home Sleep Test

Medical Affairs Policy

Sleep and the Heart. Physiologic Changes in Cardiovascular Parameters during Sleep

Sleep and the Heart. Rami N. Khayat, MD

Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015

Excessive Daytime Sleepiness Associated with Insufficient Sleep

About VirtuOx. Was marketed exclusively by Phillips Healthcare division, Respironics for 3 years

Sleep Labs are Obsolete for Perioperative Assessment of Sleep-Disordered Breathing: Pro

Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine

Transcription:

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Polysomnography for Obstructive Sleep Apnea Should Include Arousal-Based Scoring: An American Academy of Sleep Medicine Position Statement Raman K. Malhotra, MD 1 ; Douglas B. Kirsch, MD 2 ; David A. Kristo, MD 3 ; Eric J. Olson, MD 4 ; Rashmi N. Aurora, MD, MHS 5 ; Kelly A. Carden, MD, MBA 6 ; Ronald D. Chervin, MD, MS 7 ; Jennifer L. Martin, PhD 8,9 ; Kannan Ramar, MD 4 ; Carol L. Rosen, MD 10 ; James A. Rowley, MD 11 ; Ilene M. Rosen, MD, MS 12 ; American Academy of Sleep Medicine Board of Directors 1Washington University Sleep Center, St. Louis, Missouri; 2Carolinas Healthcare Medical Group Sleep Services, Charlotte, North Carolina; 3University of Pittsburgh, Pittsburgh, Pennsylvania; 4Division of Pulmonary and Critical Care Medicine, Center for Sleep Medicine, Mayo Clinic, Rochester, Minnesota; 5Johns Hopkins School of Medicine, Baltimore, Maryland; 6Saint Thomas Medical Partners - Sleep Specialists, Nashville, Tennessee; 7University of Michigan Sleep Disorders Center, Ann Arbor, Michigan; 8Veterans Affairs Greater Los Angeles Healthcare System, North Hills, California; 9David Geffen School of Medicine at the University of California, Los Angeles, California; 10Department of Pediatrics, Case Western Reserve University, University Hospitals - Cleveland Medical Center, Cleveland, Ohio; 11Wayne State University, Detroit, Michigan; 12Division of Sleep Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Abstract 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 The diagnostic criteria for obstructive sleep apnea (OSA) in adults, as defined in the International Classification of Sleep Disorders-Third Edition, requires an increased frequency of obstructive respiratory events demonstrated by in-laboratory, attended polysomnography (PSG) or a home sleep apnea test (HSAT). However, there are currently two hypopnea scoring criteria in The American Academy of Sleep Medicine (AASM) Manual for the Scoring of Sleep and Associated Events. This dichotomy results in differences among laboratory reports, patient treatments and payer policies. Confusion occurs regarding recognizing and scoring arousal-based respiratory events during OSA testing. Arousal-based scoring recognizes hypopneas associated with electroencephalography-based arousals, with or without significant oxygen desaturation, when calculating an apnea-hypopnea index (AHI), or it includes respiratory effort-related arousals (RERAs), in addition to hypopneas and apneas, when calculating a respiratory disturbance index (RDI). Respiratory events associated with arousals, even without oxygen desaturation, cause significant, and potentially dangerous, sleep apnea symptoms. During PSG, arousalbased respiratory scoring should be performed in the clinical evaluation of patients with suspected OSA, especially in those patients with symptoms of excessive daytime sleepiness, fatigue, insomnia, or other neurocognitive symptoms. Therefore, it is the position of the AASM that the RECOMMENDED AASM scoring criteria for hypopneas, which includes diminished airflow accompanied by either an arousal or 3% desaturation, should be used to calculate the AHI. If the ACCEPTABLE AASM criteria for scoring 1

37 38 39 40 41 42 43 44 45 46 hypopneas, which includes only diminished airflow plus 4% desaturation (and does not allow for arousalbased scoring alone), must be utilized due to payer policy requirements, then the RECOMMENDED AASM hypopneas should also be scored. Alternatively, The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications includes an option to report an RDI which also provides an assessment of the sleep-disordered breathing that results in arousal from sleep. Furthermore, given the inability of most HSAT devices to capture arousals, a PSG should be performed in any patient with an increased risk for OSA whose HSAT is negative. If the polysomnogram yields an AHI of 5 or more events/hour, or if the RDI is greater than or equal to 5 events/hour, then treatment of symptomatic patients is recommended to improve quality of life, limit neurocognitive symptoms, and reduce accident risk. 2

47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 Introduction The American Academy of Sleep Medicine (AASM) is the leading professional society dedicated to promotion of sleep health. The AASM improves sleep health and fosters high-quality, patient-centered care through advocacy, education, strategic research, and practice standards. The AASM endeavors to advance sleep health policy that improves the health and well-being of the general public. Obstructive sleep apnea (OSA) is characterized by repetitive episodes of complete (apnea) or partial (hypopnea) upper airway obstruction during sleep. Per the AASM International Classification of Sleep Disorders (ICSD-3), diagnostic criteria for adults include either having 1) five or more predominantly obstructive respiratory events (obstructive and mixed apneas, hypopneas, or respiratory effort-related arousals [RERAs]) per hour of sleep during polysomnography (PSG) or per hour of monitoring time during a home sleep apnea test (HSAT) with symptoms or comorbidities or 2) fifteen or more predominantly obstructive respiratory events per hour of sleep during PSG or per hour of monitoring time during an HSAT. 1 Patients who exclusively have RERAs were previously designated as having Upper Airway Resistance Syndrome, but this diagnosis is now subsumed under the heading of OSA in the ICSD-3 given the shared pathophysiology and response to treatment. Sleep apnea testing results are calculated as an apnea-hypopnea index (AHI) or respiratory disturbance index (RDI) for PSG or a respiratory event index (REI) for an HSAT, which is based on monitoring time since total sleep time based on electroencephalography (EEG) is often not recorded when using an HSAT. 65 66 67 68 69 However, there exists confusion among some clinicians and payers regarding the recognition and scoring of arousal-based respiratory events during sleep apnea testing. Arousal-based scoring recognizes hypopneas associated with EEG-based arousals, with or without significant oxygen desaturation, when calculating an AHI, and includes RERAs, in addition to hypopneas and apneas, when calculating RDI [RDI = (# apneas + # hypopneas + # RERAs) x 60/total sleep time in minutes]. 70 71 72 73 74 75 The definition of respiratory events, particularly hypopneas, has evolved over time as advancing technology has allowed for improved detection of reduced airflow. The RECOMMENDED hypopnea definition in the current version of The AASM Manual for the Scoring of Sleep and Associated Events asserts the importance of recognizing respiratory events leading to arousal. The current RECOMMENDED scoring criteria for a hypopnea are as follows 2 : Score a respiratory event as a hypopnea if ALL of the following criteria are met: 3

76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 a. The peak signal excursions drop by 30% of pre-event baseline using nasal pressure (diagnostic study), positive airway pressure (PAP) device flow (titration study), or an alternative hypopnea sensor (diagnostic study). b. The duration of the 30% drop in signal excursion is 10 seconds. c. There is a 3% oxygen desaturation from pre-event baseline or the event is associated with an arousal. The current scoring criteria for an RERA in the AASM Scoring Manual are as follows 2 : If electing to score respiratory effort-related arousals, score a respiratory event as a respiratory effortrelated arousal (RERA) if there is a sequence of breaths lasting 10 seconds characterized by increasing respiratory effort or by flattening of the inspiratory portion of the nasal pressure (diagnostic study) or PAP device flow (titration study) waveform leading to arousal from sleep when the sequence of breaths does not meet criteria for an apnea or hypopnea. As new research increasingly uncovers the many negative outcomes associated with OSA, 3 it is crucial to accurately score all respiratory events, including those with arousal, in order to effectively diagnose and treat all OSA patients. Position For scoring respiratory events, it is the position of the AASM that: 1. The RECOMMENDED AASM scoring criteria for hypopneas should be utilized in the clinical evaluation of patients with suspected OSA. By accounting for both oxygen desaturations and arousals, the RECOMMENDED AASM scoring criteria helps more definitively rule out the presence of OSA in patients with symptoms of excessive daytime sleepiness, fatigue, insomnia or other neurocognitive symptoms. 2. Even if a sleep center must use the ACCEPTABLE AASM scoring criteria for hypopneas (the criteria currently used by the Centers for Medicare and Medicaid Services) due to payer policy requirements, respiratory events that include arousals should be captured either by scoring hypopneas using the RECOMMENDED AASM scoring criteria or optionally by reporting an RDI. Reporting either would still allow the interpreting physician to diagnose OSA based upon ICSD-3 criteria. If the polysomnogram yields an AHI (using the RECOMMENDED definition) of 5 or more events/hour, or if the RDI is greater than or equal to 5 events/hour, then treatment of symptomatic patients is recommended to improve quality of life, limit neurocognitive symptoms, and reduce accident risk. 3. An in-laboratory PSG should be performed 4 when the results of an HSAT are negative in a patient with increased risk for OSA. Because identification of arousal-based respiratory events is 4

108 109 challenging when using most HSAT devices, given the absence of EEG data, the RECOMMENDED AASM scoring criteria requiring arousal cannot be applied. 110 Discussion 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 Using different criteria for scoring hypopneas can alter determinations made about diagnoses when evaluating patients with suspected OSA. 5 A patient presenting with classic OSA symptoms such as snoring, witnessed apneas, and daytime sleepiness may fail to be diagnosed with OSA if arousal-based scoring is not utilized when interpreting their polysomnogram. Studies have shown that not utilizing arousal-based scoring may lead to a missed diagnosis in up to 30-40% of patients with OSA, especially in patients who are younger and non-obese. 6 There may be instances in which a sleep center must use the ACCEPTABLE AASM scoring criteria for hypopneas due to requirements in payer policies. In these situations, either hypopneas using the RECOMMENDED AASM scoring criteria should also be scored or optionally an RDI reported. Not including arousal-based respiratory events of any form when scoring a polysomnogram may lead to either lack of proper diagnosis of OSA, misclassification of OSA severity, or misidentification of another sleep disorder or medical disorder (e.g. idiopathic hypersomnia, chronic fatigue syndrome). These patients may remain improperly treated, leading to persistent sleep symptoms, worsened work performance, decreased neurocognitive function, and poor clinical outcomes. 7 Evidence demonstrates that arousals, and not hypoxemia, better predict hypersomnia in patients with OSA. 8-10 Eliminating sleep fragmentation, even with persistent hypoxemia, improved sleepiness compared with baseline. 11 Existing data also support inclusion of RERAs in order to fully define sleep-disordered breathing. 12 Consequently, there is insufficient evidence to support the use of hypoxemia as a singular, disease-defining trait for OSA, and some of the cardinal features of OSA, such as daytime sleepiness, cannot be explained by hypoxemia alone. 11 Conclusions The definition of OSA has evolved over time as research has continued to improve our understanding of the pathophysiology and significance of sleep-related breathing disorders. Current evidence emphasizes the importance of using arousal-based scoring of respiratory events when evaluating patients suspected of having OSA. 135 5

136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 References 1. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014. 2. Berry RB, Brooks R, Gamaldo CE, et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Darien, IL: American Academy of Sleep Medicine; 2017. 3. Farrell PC, Richards G. Recognition and treatment of sleep-disordered breathing: an important component of chronic disease management. J Transl Med. 2017;15(1):114. 4. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(3):479-504. 5. Ruehland WR, Rochford PD, O'Donoghue FJ, Pierce RJ, Singh P, Thornton AT. The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index. Sleep. 2009;32(2):150-7. 6. Guilleminault C, Hagen CC, Huynh NT. Comparison of hypopnea definitions in lean patients with known obstructive sleep apnea hypopnea syndrome (OSAHS). Sleep Breath. 2009;13(4):341-7. 7. Kristo DA, Lettieri CJ, Andrada T, Taylor Y, Eliasson AH. Silent upper airway resistance syndrome: prevalence in a mixed military population. Chest. 2005;127(5):1654-7. 8. Koch H, Schneider LD, Finn LA, et al. Breathing Disturbances Without Hypoxia Are Associated With Objective Sleepiness in Sleep Apnea. Sleep. 2017;40(11). 9. Roehrs T, Zorick F, Wittig R, Conway W, Roth T. Predictors of objective level of daytime sleepiness in patients with sleep-related breathing disorders. Chest. 1989;95(6):1202-6. 10. Stepanski EJ. The effect of sleep fragmentation on daytime function. Sleep. 2002;25(3):268-76. 11. Colt HG, Haas H, Rich GB. Hypoxemia vs sleep fragmentation as cause of excessive daytime sleepiness in obstructive sleep apnea. Chest. 1991;100(6):1542-8. 12. Redline S, Budhiraja R, Kapur V, et al. The scoring of respiratory events in sleep: reliability and validity. J Clin Sleep Med. 2007;3(2):169-200. Acknowledgements The AASM board of directors thanks and acknowledges the contributions of Richard B. Berry MD, who served as a critical reviewer of this position statement. Submission & Correspondence Information Address correspondence to: Raman K. Malhotra, MD, Washington University Sleep Center, 1600 South Brentwood Boulevard, #600, St. Louis, MO 63144. Tel: (314)-362-4342; Fax (314) 747-3813; Email: raman.malhotra@wustl.edu Disclosure Statement The authors comprise the 2017 2018 board of directors of the American Academy of Sleep Medicine. This position statement was developed by the board of directors of the AASM to improve the diagnosis of OSA. It is published by the AASM as an advisory that is to be used for educational and informational purposes only. 6